Endometriosis and risk of ovarian cancer: what do we know?
Purpose Despite long and intensive research, endometriosis remains one of the leading
causes of morbidity among premenopausal women. The majority of endometriosis-related …
causes of morbidity among premenopausal women. The majority of endometriosis-related …
Targeting Nrf2 may reverse the drug resistance in ovarian cancer
D Li, X Hong, F Zhao, X Ci, S Zhang - Cancer Cell International, 2021 - Springer
Background Acquired resistance to therapeutic drugs has become an important issue in
treating ovarian cancer. Studies have shown that the prevalent chemotherapy resistance …
treating ovarian cancer. Studies have shown that the prevalent chemotherapy resistance …
Mitochondrial fission causes cisplatin resistance under hypoxic conditions via ROS in ovarian cancer cells
Mitochondria undergo fission and fusion continually for survival through the course of
cellular adaption processes in response to changes in the surrounding environment …
cellular adaption processes in response to changes in the surrounding environment …
High throughput proteomics identifies a high-accuracy 11 plasma protein biomarker signature for ovarian cancer
S Enroth, M Berggrund, M Lycke, J Broberg… - Communications …, 2019 - nature.com
Ovarian cancer is usually detected at a late stage and the overall 5-year survival is only 30–
40%. Additional means for early detection and improved diagnosis are acutely needed. To …
40%. Additional means for early detection and improved diagnosis are acutely needed. To …
Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in …
A Yoshimura, K Sawada, K Nakamura, Y Kinose… - BMC cancer, 2018 - Springer
Background microRNAs (miRNAs) stably exist in circulating blood and are encapsulated in
extracellular vesicles such as exosomes. The aims of this study were to identify which …
extracellular vesicles such as exosomes. The aims of this study were to identify which …
[HTML][HTML] Role of biomarkers for early detection of ovarian cancer recurrence
P Giampaolino, V Foreste, L Della Corte… - Gland …, 2020 - ncbi.nlm.nih.gov
Ovarian cancer is frequently diagnosed at an advanced stage and a fraction of these
patients fail to respond to primary therapy and relapses in 70% of cases. On account of the …
patients fail to respond to primary therapy and relapses in 70% of cases. On account of the …
Fucoidan Derived from Fucus vesiculosus Inhibits the Development of Human Ovarian Cancer via the Disturbance of Calcium Homeostasis, Endoplasmic Reticulum …
Marine organisms are sources of several natural compounds with potential clinical use.
However, only a few marine-based pharmaceuticals have been approved for use due to …
However, only a few marine-based pharmaceuticals have been approved for use due to …
Aptamer biosensing based on metal enhanced fluorescence platform: A promising diagnostic tool
SM Sundaresan, SM Fothergill, TA Tabish… - Applied Physics …, 2021 - pubs.aip.org
Diagnosis of disease at an early, curable, and reversible stage allows more conservative
treatment and better patient outcomes. Fluorescence biosensing is a widely used method to …
treatment and better patient outcomes. Fluorescence biosensing is a widely used method to …
Potential role of vaginal microbiota in ovarian cancer carcinogenesis, progression and treatment
X Zhao, Z Liu, T Chen - Pharmaceutics, 2023 - mdpi.com
Ovarian cancer represents one of the most challenging gynecologic cancers which still has
numerous unknowns on the underlying pathogenesis. In addition to the verified contributors …
numerous unknowns on the underlying pathogenesis. In addition to the verified contributors …
Chrysophanol induces cell death and inhibits invasiveness via mitochondrial calcium overload in ovarian cancer cells
Chrysophanol is a phytochemical typically extracted from rhubarb. Similar to other extracts
from rhubarb, chrysophanol possesses anticancer activity against diverse cancerous cells …
from rhubarb, chrysophanol possesses anticancer activity against diverse cancerous cells …